These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32858049)

  • 1. A novel phosphodiesterase 4 inhibitor, AA6216, reduces macrophage activity and fibrosis in the lung.
    Matsuhira T; Nishiyama O; Tabata Y; Kaji C; Kubota-Ishida N; Chiba Y; Sano H; Iwanaga T; Tohda Y
    Eur J Pharmacol; 2020 Oct; 885():173508. PubMed ID: 32858049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophages.
    Matsuhira T; Nishiyama O; Tabata Y; Kurashimo S; Sano H; Iwanaga T; Tohda Y
    Biochem Biophys Rep; 2021 Dec; 28():101118. PubMed ID: 34485715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
    Zhu T; Zhang W; Xiao M; Chen H; Jin H
    Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
    Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
    PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
    Udalov S; Dumitrascu R; Pullamsetti SS; Al-tamari HM; Weissmann N; Ghofrani HA; Guenther A; Voswinckel R; Seeger W; Grimminger F; Schermuly RT
    BMC Pulm Med; 2010 May; 10():26. PubMed ID: 20444277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.
    Tanaka R; Watanabe H; Kodama A; Chuang VT; Ishima Y; Hamasaki K; Tanaka K; Mizushima T; Otagiri M; Maruyama T
    J Pharmacol Exp Ther; 2013 May; 345(2):271-83. PubMed ID: 23442250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in circulating and alveolar compartments.
    Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Guo ZZ; Sun HY; Hu DC; Yang GH; Li YM; Wei LQ
    PLoS One; 2013; 8(11):e81090. PubMed ID: 24260540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.
    Nakagome K; Dohi M; Okunishi K; Tanaka R; Miyazaki J; Yamamoto K
    Thorax; 2006 Oct; 61(10):886-94. PubMed ID: 16809410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
    Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
    PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of a novel phosphodiesterase-4 inhibitor, AA6216, in mouse dermatitis models.
    Kubota-Ishida N; Matsuhira T; Kaji C; Kikuchi C; Tabata Y
    Eur J Pharmacol; 2021 Sep; 906():174258. PubMed ID: 34139195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of CYTL1 attenuates bleomycin-induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF-β/CCN2 axis.
    Wang Y; Liu C; Xie Y; Li X
    Clin Exp Pharmacol Physiol; 2024 Sep; 51(9):e13913. PubMed ID: 39103233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
    Dong SH; Liu YW; Wei F; Tan HZ; Han ZD
    Biomed Pharmacother; 2017 May; 89():1297-1309. PubMed ID: 28320097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice.
    Li F; Han F; Li H; Zhang J; Qiao X; Shi J; Yang L; Dong J; Luo M; Wei J; Liu X
    Mol Immunol; 2017 Oct; 90():11-21. PubMed ID: 28662409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.